FY22业绩符合预期,温和复苏可期
Nayuki Holdings Limited (2150 HK) 期待 FY22E 的数字化
Resilient FY22/1H23 despite industry headwinds
华润医药:1H22业绩巩固了FY22E的正面
石四药集团:强劲的1H22结果;但FY22E指引略低
FY22 net margins better than expected
FY22业绩不及预期;零售能力强化
FY22E preview; Bumpy recovery in 2023
遥望科技(002291)FY22&1Q23业绩交流会-调研纪要
Outperforming FY22E, promising FY23E and not-far-fetching FY25E target